SG Americas Securities’s Xeris Biopharma Holdings XERS Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$707K	Buy	121,911 +11,731	+11%	+$77.8K	﹤0.01%	1979
2025 Q4	$865K	Buy	110,180 +26,966	+32%	+$212K	﹤0.01%	2132
2025 Q3	$677K	Buy	83,214 +63,921	+331%	+$425K	﹤0.01%	1844
2025 Q2	$90K	Sell	19,293 -51,206	-73%	-$235K	﹤0.01%	2659
2025 Q1	$387K	Sell	70,499 -24,172	-26%	-$97.6K	﹤0.01%	1991
2024 Q4	$321K	Buy	94,671 +34,469	+57%	+$111K	﹤0.01%	1735
2024 Q3	$172K	Buy	60,202 +39,335	+189%	+$101K	﹤0.01%	2617
2024 Q2	$47K	Sell	20,867 -150	-0.7%	-$302	﹤0.01%	2685
2024 Q1	$46K	Sell	21,017 -12,760	-38%	-$33K	﹤0.01%	2782
2023 Q4	$79K	Buy	33,777 +15,414	+84%	+$28.4K	﹤0.01%	2836
2023 Q3	$34K	Buy	+18,363	New	+$42.1K	﹤0.01%	2998
2023 Q2	–	Sell	-40,947	Closed	-$67K	–	3263
2023 Q1	$67K	Buy	+40,947	New	+$51.3K	﹤0.01%	3018
2022 Q4	–	Sell	-25,397	Closed	-$40K	–	3423
2022 Q3	$40K	Buy	+25,397	New	+$42K	﹤0.01%	3028
2021 Q3	–	Sell	-244,228	Closed	-$994K	–	3914
2021 Q2	$994K	Buy	+244,228	New	+$932K	﹤0.01%	1559
2020 Q3	–	Sell	-20,438	Closed	-$54K	–	3536
2020 Q2	$54K	Buy	20,438 +7,215	+55%	+$25.1K	﹤0.01%	3520
2020 Q1	$26K	Buy	+13,223	New	+$56.9K	﹤0.01%	3275